DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,433,000 | +20.1% | 765,550 | +122.3% | 0.04% | +17.6% |
| Q2 2021 | $12,851,000 | +43.1% | 344,350 | -1.9% | 0.03% | +36.0% |
| Q1 2021 | $8,979,000 | -23.4% | 351,150 | -34.0% | 0.02% | -19.4% |
| Q4 2020 | $11,721,000 | -0.6% | 532,050 | -18.8% | 0.03% | -8.8% |
| Q3 2020 | $11,790,000 | -25.4% | 655,350 | +5.3% | 0.03% | -26.1% |
| Q2 2020 | $15,813,000 | +39.2% | 622,550 | +0.7% | 0.05% | +7.0% |
| Q1 2020 | $11,357,000 | +17.0% | 618,250 | +40.3% | 0.04% | +87.0% |
| Q4 2019 | $9,705,000 | +635.2% | 440,550 | +379.1% | 0.02% | +666.7% |
| Q3 2019 | $1,320,000 | -29.9% | 91,950 | -23.1% | 0.00% | -40.0% |
| Q2 2019 | $1,883,000 | -4.3% | 119,550 | -10.9% | 0.01% | 0.0% |
| Q1 2019 | $1,967,000 | +11.1% | 134,250 | -18.9% | 0.01% | 0.0% |
| Q4 2018 | $1,770,000 | -38.0% | 165,550 | -11.4% | 0.01% | -28.6% |
| Q3 2018 | $2,853,000 | +46.6% | 186,950 | +17.7% | 0.01% | +40.0% |
| Q2 2018 | $1,946,000 | +1906.2% | 158,850 | +1472.8% | 0.01% | – |
| Q1 2018 | $97,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |